Last Updated: June 22, 2026

FLECAINIDE Drug Patent Profile

Name: FLECAINIDE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Flecainide patents expire, and what generic alternatives are available?

Flecainide is a drug marketed by Amneal Pharm, Ani Pharms, Aurobindo Pharma Ltd, Chartwell, Hikma, Omsav Pharma, Regcon Holdings, Sun Pharm Inds Ltd, and Yichang Humanwell. and is included in ten NDAs.

The generic ingredient in FLECAINIDE is flecainide acetate. There are ten drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the flecainide acetate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Flecainide

A generic version of FLECAINIDE was approved as flecainide acetate by AMNEAL PHARM on July 31^st, 2001.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for FLECAINIDE?
What are the global sales for FLECAINIDE?
What is Average Wholesale Price for FLECAINIDE?

Summary for FLECAINIDE

US Patents:	0
Applicants:	9
NDAs:	10
Drug Prices:	Drug price information for FLECAINIDE
Drug Sales Revenues:	Drug sales revenues for FLECAINIDE
DailyMed Link:	FLECAINIDE at DailyMed

Drug patent expirations by year for FLECAINIDE

US Patents and Regulatory Information for FLECAINIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Yichang Humanwell	FLECAINIDE ACETATE	flecainide acetate	TABLET;ORAL	215599-001	Sep 8, 2022	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Yichang Humanwell	FLECAINIDE ACETATE	flecainide acetate	TABLET;ORAL	215599-002	Sep 8, 2022	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Amneal Pharm	FLECAINIDE ACETATE	flecainide acetate	TABLET;ORAL	075442-001	Jul 31, 2001	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for FLECAINIDE

Side affects of flecainide?
Flecainide cost with insurance?
Flecainide production cost?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.